Latest filing published 08 Aug 2016 for Arcadia Biosciences, Inc., €97.
Insider track record
Roger Salameh: trading record in brief
All filings by Roger Salameh on record concern Arcadia Biosciences, Inc. In total, 10 filings cover trades dated from 8 September 2015 to 4 August 2016.
Every open-market trade on record is a sale: 5 sales worth €46k. Other entries cover 5 option exercises. Since January 2016: no purchases and 1 sale on the market.
The record was last updated on 8 August 2016 with an option exercise (€97) in Arcadia Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Roger Salameh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100 shares@ US$1.0830.1% of flowCommon StockSEC:0001209191-16-135912:0
- 100 shares@ US$2.5169.9% of flowCommon StockSEC:0001209191-16-135912:1
- 4,603 shares@ US$0.44Common StockSEC:0001209191-15-070367:0
- 1,648 shares@ US$4.9181Common StockSEC:0001209191-15-070367:1
- 10,334 shares@ US$0.44Common StockSEC:0001209191-15-070254:0
- 3,500 shares@ US$5.5089Common StockSEC:0001209191-15-070254:1
- 8,115 shares@ US$0.44Common StockSEC:0001209191-15-070254:2
- 2,765 shares@ US$5.5458Common StockSEC:0001209191-15-070254:3
- 4,448 shares@ US$0.44Common StockSEC:0001209191-15-070254:4
- 1,575 shares@ US$5.2708Common StockSEC:0001209191-15-070254:5
10 of 10 declarations